Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 730 of 1,261
  1. US 9149475

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  2. US 9150598

    Masking apertures enabling automation and solution exchange in sessile bilayers

    The Regents of the University of California · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  3. US 9149537

    Compositions and methods for the treatment of traumatic brain injury

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  4. US 9150552

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid

    Vertex Pharmaceuticals Incorporated · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  5. US 9150500

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  6. US 9151762

    Identification of DSG-3 as a biomarker for the detection of metastasis in lymph nodes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  7. US 9150847

    Methods and compositions for regulation of transgene expression

    Sangamo Biosciences, Inc. · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  8. US 9150616

    Immunoregulatory peptides and methods of use

    Compass Therapeutics LLC · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  9. US 9149542

    Microvesicles derived from cell protoplast and use thereof

    Aeon Medix Inc. · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  10. US 9150831

    Conditionally immortalized long-term stem cells and methods of making and using such cells

    The Regents of the University of Colorado · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  11. US 9150644

    Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  12. US 9150926

    Diagnosis and treatment of adrenocortical tumors using human microRNA-483

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  13. US 9150862

    siRNA targeting VEGFA and methods for treatment in vivo

    Arrowhead Research Corporation · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  14. US 9150837

    Polyethylene glycolated superoxide dismutase mimetics

    Galera Labs, LLC · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  15. US 9151755

    Methods for detecting Ehrlichia infection

    Boards of Regents, The University of Texas System · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  16. US 9150928

    Diagnosing and monitoring CNS malignancies using MicroRNA

    The Regents of the University of California · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  17. US 9150648

    Anti-ASIC1 antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  18. US 9150600

    Triptolide prodrugs

    Regents of the University of Minnesota · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  19. US 9150617

    Immunoregulatory peptides and methods of use

    Compass Therapeutics LLC · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  20. US 9150591

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  21. US 9150588

    Substituted pyridazin-4(1H)-ones as phosphodiesterase 10A inhibitors

    Takeda Pharmaceutical Company Limited · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  22. US 9150533

    Local cochlear application of statins for stimulating neurite regrowth in the cochlea

    Northwestern University · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  23. US 9150514

    Dual-acting antihypertensive agents

    Theravance Biopharma R&D IP, LLC · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted
  24. US 9149538

    Oligomer conjugates of heteropentacyclic nucleosides

    Nektar Therapeutics · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.